Position in URGN
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$623,923
-$68,361 QoQ
Shares Held
34,701
0.0% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BENDER ROBERT & ASSOCIATES holds $12,310,321 across 2 Biotechnology names. URGN ranks #2 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
26,171 | $11,686,398 | |
| 2 | URGN |
UroGen Pharma Ltd.
This page
|
34,701 | $623,923 |
All Filings in URGN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $623,923 | 34,701 | Shares | Sole | 2026-04-23 | |
| 2025-09-30 | $692,284 | 34,701 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $475,403 | 34,701 | Shares | Sole | 2025-07-24 | |
| 2024-12-31 | $369,565 | 34,701 | Shares | Sole | 2025-02-07 | |
| 2024-03-31 | $520,515 | 34,701 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $520,515 | 34,701 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $486,161 | 34,701 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $359,155 | 34,701 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $320,637 | 34,701 | Shares | Sole | 2023-04-21 | |
| 2022-09-30 | $342,209 | 41,131 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $336,862 | 41,131 | Shares | Sole | 2022-07-19 | |
| 2021-03-31 | $606,431 | 31,131 | Shares | Sole | 2021-04-28 | |
| No filing history on record for this holder in this stock. | ||||||